CV SCIENCES, INC. (OTCMKTS:CVSI) Files An 8-K Results of Operations and Financial ConditionItem 2.02
The information provided below in “Item 7.01 – Regulation FD Disclosure” of this Current Report on Form 8-K is incorporated by reference into this Item 2.02.
| Item 7.01 | Regulation FD Disclosure |
On August 4, 2018, Dr. Joseph C. Maroon, a Board-Certified Neurosurgeon presented materials titled Cannabidiol (CBD): Therapeutic Uses for Health and Wellness (the “Maroon Presentation”) as a guest of CV Sciences, Inc. (the “Company”) at its Investor Day following the conclusion of its 2018 Annual Meeting of Stockholders. Following Dr. Maroon’s presentation, the Company’s Chief Executive Officer, Joseph Dowling, presented materials titled CV Sciences, a Life Sciences Company, CBD-Based Pharmaceutical & Consumer Products – Corporate Presentation (together with the Maroon Presentation, the “Materials”). Some of the information in the Materials and disclosed at the Investor Day was not previously disclosed publicly and as a result the Materials are furnished as Exhibit 99.1 and Exhibit 99.2 hereto and incorporated herein by reference.
Exhibit 99.1 and Exhibit 99.2 contain forward-looking statements. These forward-looking statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Forward-looking statements are based upon assumptions as to future events that may not prove to be accurate. Actual outcomes and results may differ materially from what is expressed in these forward-looking statements.
The information set forth under Item 7.01 of this Current Report on Form 8-K (“Current Report”), including Exhibit 99.1 and Exhibit 99.2 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of such section. The information in Item 7.01 of this Current Report, including Exhibit 99.1 and Exhibit 99.2, shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any incorporation by reference language in any such filing, except as expressly set forth by specific reference in such a filing. This Current Report will not be deemed an admission as to the materiality of any information in this Current Report that is required to be disclosed solely by Regulation FD.
| Item 9.01 | Financial Statements and Exhibits. |
CV Sciences, Inc. ExhibitEX-99.1 2 cv_ex9901.htm HEALTH AND WELLNESS PRESENTATION Exhibit 99.1 Cannabidiol (CBD) Therapeutic Uses for Health and Wellness Joseph C. Maroon,…To view the full exhibit click here
About CV SCIENCES, INC. (OTCMKTS:CVSI)
CV Sciences, Inc. is a life science company. The Company operates in two segments: specialty pharmaceuticals and consumer products. The Company’s specialty pharma business segment is focused on developing and commercializing therapeutics utilizing synthetic Cannabidiol (CBD) across several therapeutic areas. The consumer product business segment is focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors.